Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    -50.00 (-0.91%)
Bid:
5,400.00
Ask:
5,500.00
Spread: 100.00 (1.852%)
Market Cap: £139.03m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

6 Jun 2024 07:00

RNS Number : 3086R
Camellia PLC
06 June 2024
 

6 June 2024

Camellia Plc

(the "Company" or the "Group")

 

Trading update

 

 

 

Tea

India: Production in May in all regions has been severely affected by very dry weather which is also expected to impact yields in June. While there are some early signs that prices for Assam and Darjeeling teas may be improving, it is too early in the season to adjust our forecasts. In the face of a substantial tightening of regulations around the use of chemicals in the growing process, the India subsidiary companies have decided to materially reduce bought leaf production as a risk mitigation strategy.

 

Bangladesh: Following industry discussions with the Bangladesh Tea Board, a fair pricing mechanism is being developed with the objective of improving prices and margins for producers. Other initiatives to support the industry, are also under consideration by government. While these are positive developments they are at an early stage and the scale of impact is not clear. 

 

Kenya: Favourable weather meant crops in May were higher than expected. However, as mentioned in our annual report, significant stocks of tea have been building up in the Kenya industry over recent years. With the revised minimum pricing mechanism, these are now being released to the market for sale with a significantly bigger impact on tea prices in the last month than expected. It looks like these lower prices are likely to continue for the remainder of this year. There is no obvious catalyst for prices to improve and in fact they may further weaken. Estimating the scale of this and hence the impact on our prices is difficult at this early stage in the year. The strength of the Kenya shilling remains a headwind.

 

Malawi: Weaker prices in Kenya have also impacted Malawi tea demand with further softening of prices in this market too. Production volumes in Malawi remain in line with expectations. 

 

Other crops

Other crops are performing in line with the guidance previously given.

 

BF&M

As mentioned in the annual report, the disposal of our interest in BF&M to Argus Group has been more complex and the approval process more protracted than expected. While we are still confident the sale of our stake will go ahead, further delays in the regulatory approval process mean we now expect completion in the latter part of 2024. The sale of BF&M is expected to result in cash consideration of $100m payable to Camellia, before expenses.

 

Bardsley

Progress has been made in the closure of the Bardsley's operation. We have now exited the two major leases and negotiations with the remaining landlords are ongoing. Asset disposals are also underway and we are on track to conclude the winding up process before the end of the year.

 

We expect to report a reduced loss for the year from Bardsley in the range of £3.5-4.5 million (2023: Loss £15.6 million). This includes the trading loss as well as the estimated cost of exiting leases, impairments, closure costs and the results of asset disposals. We expect a net cash recovery from the closure of £4-5 million. It is expected that Bardsley will be accounted for as a 'Discontinued operation' in 2024. 

 

Outlook for the year for continuing operations

Forecasting the outcome for the year at this stage in the year is difficult, not least because the majority of our production and sales occurs in the second half of the year. That said, despite reduced tea production expectations in India and further reductions in tea prices in Kenya and Malawi we continue to expect revenue above that of 2023. However, the outlook for the adjusted loss before tax for continuing operations has worsened from our previous guidance and is now at between £10-12 million (2023: £2.5 million loss).

 

Camellia had net cash of £21.7 million and investment portfolios with a market value of £38.1 million at 31 March 2024.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Byron Coombs, CEO

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisors Maitland 

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZGGVVKKGDZM
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.